
Sign up to save your podcasts
Or


Today we’re joined by Bharath Ramsundar, founder and CEO of Deep Forest Sciences. In our conversation with Bharath, we explore his work on the DeepChem, an open-source library for drug discovery, materials science, quantum chemistry, and biology tools. We discuss the challenges that biotech and pharmaceutical companies are facing as they attempt to incorporate AI into the drug discovery process, where the innovation frontier is, and what the promise is for AI in this field in the near term. We also dig into the origins of DeepChem and the problems it's solving for practitioners, the capabilities that are enabled when using this library as opposed to others, and MoleculeNET, a dataset and benchmark focused on molecular design that lives within the DeepChem suite.
The complete show notes for this episode can be found at twimlai.com/go/566
By Sam Charrington4.7
419419 ratings
Today we’re joined by Bharath Ramsundar, founder and CEO of Deep Forest Sciences. In our conversation with Bharath, we explore his work on the DeepChem, an open-source library for drug discovery, materials science, quantum chemistry, and biology tools. We discuss the challenges that biotech and pharmaceutical companies are facing as they attempt to incorporate AI into the drug discovery process, where the innovation frontier is, and what the promise is for AI in this field in the near term. We also dig into the origins of DeepChem and the problems it's solving for practitioners, the capabilities that are enabled when using this library as opposed to others, and MoleculeNET, a dataset and benchmark focused on molecular design that lives within the DeepChem suite.
The complete show notes for this episode can be found at twimlai.com/go/566

480 Listeners

1,089 Listeners

170 Listeners

303 Listeners

334 Listeners

208 Listeners

201 Listeners

95 Listeners

512 Listeners

130 Listeners

227 Listeners

608 Listeners

25 Listeners

35 Listeners

40 Listeners